FDA Files Rejoni’s Juveena® Hydrogel System PMA for the Prevention of Intrauterine Adhesions

[#item_full_content]BEDFORD, Mass.–(BUSINESS WIRE)–Rejoni, Inc., a clinical-stage company focused on uterine health, today announced that the U.S.…

Alkaren misses BLAST Bounty due to visa issues

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]